{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:22:14Z","timestamp":1790284934133,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00262-012-1331-4","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T11:14:26Z","timestamp":1345806866000},"page":"347-357","source":"Crossref","is-referenced-by-count":39,"title":["CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells"],"prefix":"10.1007","volume":"62","author":[{"given":"Masayasu","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Hainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute E.","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ahove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Rajasagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baogong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselmo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Witten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Duke-Cohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon J.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,25]]},"reference":[{"issue":"5","key":"1331_CR1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.178.5.1567","volume":"178","author":"TM Foy","year":"1993","unstructured":"Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 178(5):1567\u20131575. doi: 10.1084\/jem.178.5.1567","journal-title":"J Exp Med"},{"issue":"3","key":"1331_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","volume":"9","author":"C Kooten van","year":"1997","unstructured":"van Kooten C, Banchereau J (1997) Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9(3):330\u2013337. doi: 10.1016\/S0952-7915(97)80078-7","journal-title":"Curr Opin Immunol"},{"key":"1331_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","volume":"16","author":"IS Grewal","year":"1998","unstructured":"Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111\u2013135. doi: 10.1146\/annurev.immunol.16.1.111","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1331_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","volume":"67","author":"C Kooten van","year":"2000","unstructured":"van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67(1):2\u201317","journal-title":"J Leukoc Biol"},{"issue":"7","key":"1331_CR5","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1182\/blood-2004-01-0113","volume":"107","author":"M Bergwelt-Baildon von","year":"2006","unstructured":"von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S, Draube A, Maecker B, Menezes I, Nadler LM, Schultze JL (2006) CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood 107(7):2786\u20132789. doi: 10.1182\/blood-2004-01-0113","journal-title":"Blood"},{"issue":"18","key":"1331_CR6","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","volume":"92","author":"JL Schultze","year":"1995","unstructured":"Schultze JL, Cardoso AA, Freeman GJ, Seamon MJ, Daley J, Pinkus GS, Gribben JG, Nadler LM (1995) Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA 92(18):8200\u20138204. doi: 10.1073\/pnas.92.18.8200","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1331_CR7","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","volume":"100","author":"JL Schultze","year":"1997","unstructured":"Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100(11):2757\u20132765. doi: 10.1172\/JCI119822","journal-title":"J Clin Invest"},{"key":"1331_CR8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-065X.2008.00604.x","volume":"222","author":"MA Cheever","year":"2008","unstructured":"Cheever MA (2008) Twelve immunotherapy drugs that could cure cancers. Immunol Rev 222:357\u2013368. doi: 10.1111\/j.1600-065X.2008.00604.x","journal-title":"Immunol Rev"},{"issue":"5","key":"1331_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/smim.1994.1035","volume":"6","author":"WC Fanslow","year":"1994","unstructured":"Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ (1994) Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 6(5):267\u2013278. doi: 10.1006\/smim.1994.1035","journal-title":"Semin Immunol"},{"issue":"1","key":"1331_CR10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1074\/jbc.274.1.418","volume":"274","author":"AE Morris","year":"1999","unstructured":"Morris AE, Remmele RL Jr, Klinke R, Macduff BM, Fanslow WC, Armitage RJ (1999) Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154). J Biol Chem 274(1):418\u2013423. doi: 10.1074\/jbc.274.1.418","journal-title":"J Biol Chem"},{"issue":"10","key":"1331_CR11","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1002\/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F","volume":"31","author":"LE Haswell","year":"2001","unstructured":"Haswell LE, Glennie MJ, Al-Shamkhani A (2001) Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154. Eur J Immunol 31(10):3094\u20133100. doi: 10.1002\/1521-4141(2001010)31:10<3094:AID-IMMU3094>3.0.CO;2-F","journal-title":"Eur J Immunol"},{"issue":"4","key":"1331_CR12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/JVI.80.4.1762-1772.2006","volume":"80","author":"GW Stone","year":"2006","unstructured":"Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, Kornbluth RS (2006) Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol 80(4):1762\u20131772. doi: 10.1128\/JVI.80.4.1762-1772.2006","journal-title":"J Virol"},{"issue":"11","key":"1331_CR13","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1073\/pnas.95.11.5929","volume":"95","author":"CR Robinson","year":"1998","unstructured":"Robinson CR, Sauer RT (1998) Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc Natl Acad Sci USA 95(11):5929\u20135934. doi: 10.1073\/pnas.95.11.5929","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1331_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jgm.677","volume":"7","author":"L Zhang","year":"2005","unstructured":"Zhang L, Leng Q, Mixson AJ (2005) Alteration in the IL-2 signal peptide affects secretion of proteins in vitro and in vivo. J Gene Med 7(3):354\u2013365. doi: 10.1002\/jgm.677","journal-title":"J Gene Med"},{"issue":"5138","key":"1331_CR15","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.8248779","volume":"262","author":"PB Harbury","year":"1993","unstructured":"Harbury PB, Zhang T, Kim PS, Alber T (1993) A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 262(5138):1401\u20131407. doi: 10.1126\/science.8248779","journal-title":"Science"},{"issue":"4","key":"1331_CR16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/bit.10790","volume":"84","author":"AA Bianchi","year":"2003","unstructured":"Bianchi AA, McGrew JT (2003) High-level expression of full-length antibodies using trans-complementing expression vectors. Biotechnol Bioeng 84(4):439\u2013444. doi: 10.1002\/bit.10790","journal-title":"Biotechnol Bioeng"},{"issue":"16","key":"1331_CR17","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1093\/nar\/19.16.4485","volume":"19","author":"RJ Kaufman","year":"1991","unstructured":"Kaufman RJ, Davies MV, Wasley LC, Michnick D (1991) Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res 19(16):4485\u20134490. doi: 10.1093\/nar\/19.16.4485","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1331_CR18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/bp034383r","volume":"20","author":"J Running Deer","year":"2004","unstructured":"Running Deer J, Allison DS (2004) High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene. Biotechnol Prog 20(3):880\u2013889. doi: 10.1021\/bp034383r","journal-title":"Biotechnol Prog"},{"issue":"3","key":"1331_CR19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2144\/000112536","volume":"43","author":"B Zhu","year":"2007","unstructured":"Zhu B, Cai G, Hall EO, Freeman GJ (2007) In-fusion assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations. Biotechniques 43(3):354\u2013359. doi: 10.2144\/000112536","journal-title":"Biotechniques"},{"issue":"11","key":"1331_CR20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/CVI.00198-06","volume":"13","author":"GW Stone","year":"2006","unstructured":"Stone GW, Barzee S, Snarsky V, Spina CA, Lifson JD, Pillai VK, Amara RR, Villinger F, Kornbluth RS (2006) Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro. Clin Vaccine Immunol 13(11):1223\u20131230. doi: 10.1128\/CVI.00198-06","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"1331_CR21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V85.7.1903.bloodjournal8571903","volume":"85","author":"M Urashima","year":"1995","unstructured":"Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC (1995) CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85(7):1903\u20131912","journal-title":"Blood"},{"issue":"10","key":"1331_CR22","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/1078-0432.CCR-10-0415","volume":"16","author":"W Zhang","year":"2010","unstructured":"Zhang W, Choi J, Zeng W, Rogers SA, Alyea EP, Rheinwald JG, Canning CM, Brusic V, Sasada T, Reinherz EL, Ritz J, Soiffer RJ, Wu CJ (2010) Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion. Clin Cancer Res 16(10):2729\u20132739. doi: 10.1158\/1078-0432.CCR-10-0415","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1331_CR23","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V93.6.1992.406k23_1992_2002","volume":"93","author":"R Buhmann","year":"1999","unstructured":"Buhmann R, Nolte A, Westhaus D, Emmerich B, Hallek M (1999) CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood 93(6):1992\u20132002","journal-title":"Blood"},{"issue":"6045","key":"1331_CR24","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1206954","volume":"333","author":"F Li","year":"2011","unstructured":"Li F, Ravetch JV (2011) Inhibitory Fcgamma receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 333(6045):1030\u20131034. doi: 10.1126\/science.1206954","journal-title":"Science"},{"issue":"1","key":"1331_CR25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-065X.2009.00778.x","volume":"229","author":"K Chattopadhyay","year":"2009","unstructured":"Chattopadhyay K, Lazar-Molnar E, Yan Q, Rubinstein R, Zhan C, Vigdorovich V, Ramagopal UA, Bonanno J, Nathenson SG, Almo SC (2009) Sequence, structure, function, immunity: structural genomics of costimulation. Immunol Rev 229(1):356\u2013386. doi: 10.1111\/j.1600-065X.2009.00778.x","journal-title":"Immunol Rev"},{"issue":"13","key":"1331_CR26","doi-asserted-by":"crossref","first-page":"11226","DOI":"10.1074\/jbc.M110.208215","volume":"286","author":"HJ An","year":"2011","unstructured":"An HJ, Kim YJ, Song DH, Park BS, Kim HM, Lee JD, Paik SG, Lee JO, Lee H (2011) Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J Biol Chem 286(13):11226\u201311235. doi: 10.1074\/jbc.M110.208215","journal-title":"J Biol Chem"},{"issue":"6","key":"1331_CR27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2008-04-152041","volume":"112","author":"W Tu","year":"2008","unstructured":"Tu W, Lau YL, Zheng J, Liu Y, Chan PL, Mao H, Dionis K, Schneider P, Lewis DB (2008) Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112(6):2554\u20132562. doi: 10.1182\/blood-2008-04-152041","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1331-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T22:02:46Z","timestamp":1594591366000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1331-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1331-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,25]]}}}